SCHEMBL4906041

SCHEMBL4906041

CCN(c1nc(-c2ccc(F)c(Cl)c2)sc1C)S(=O)(=O)c1ccc(Cl)c(C(=O)OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
TSHR P16473 2/20 0.52
LMNA P02545 7/20 0.40
MAPT P10636 7/20 0.40
KDM4E B2RXH2 3/20 0.39
TP53 P04637 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HTT P42858 1/20 0.38
ABL1 P00519 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
PTPRC P08575 1/20 0.35
PTPN2 P17706 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905782 0.94 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4901395 0.93 ALDH1A1 (0.43) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4904036 0.92 ALDH1A1 (0.54) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4894604 0.91 ALDH1A1 (0.43) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4902748 0.90 LMNA (0.48) ALDH1A1TSHRLMNAKDM4EHTT
SCHEMBL4906433 0.90 ALDH1A1 (0.39) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4906349 0.88 ALDH1A1 (0.50) ALDH1A1TSHRLMNAMAPTKDM4E
SCHEMBL4907121 0.86 LMNA (0.47) ALDH1A1LMNAPTPRCPTPN2PTPN1
SCHEMBL4905616 0.85 LMNA (0.46) ALDH1A1LMNAHTTPSEN1PSEN2
SCHEMBL4906767 0.85 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.